CVI Holdings Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Skye Bioscience
SKYE
|
+$8.07M |
| 2 |
INmune Bio
INMB
|
+$5.88M |
| 3 |
GPATU
GP-Act III Acquisition Corp Units
GPATU
|
+$4.63M |
| 4 |
AZZ Inc
AZZ
|
+$3.22M |
| 5 |
FSHPU
Flag Ship Acquisition Corp Unit
FSHPU
|
+$3.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Spire Global
SPIR
|
+$3.13M |
| 2 |
Erasca
ERAS
|
+$3M |
| 3 |
SEDA
SDCL EDGE Acquisition Corporation
SEDA
|
+$2.55M |
| 4 |
IBACU
IB Acquisition Corp. Unit
IBACU
|
+$2.5M |
| 5 |
Achieve Life Sciences
ACHV
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 46.25% |
| 2 | Healthcare | 15.17% |
| 3 | Financials | 14.14% |
| 4 | Industrials | 3.87% |
| 5 | Consumer Staples | 1.67% |
No holdings matched the selected filter criteria.
Similar funds
CVI Holdings's Q2 2024 Portfolio in Review
As of Q2 2024, CVI Holdings held 189 positions worth $116M, up 9.2% from $106M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
CVI Holdings deployed $11.9M of net new capital in Q2 2024, opening 31 new positions and adding to 1 existing holding. Its largest new stake was Skye Bioscience: 679,739 shares worth $5.44M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 46% of assets, down from 55% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Achieve Life Sciences, an estimated $2.39M trimmed.
- CVI Holdings's largest Q2 2024 buy was Skye Bioscience: 679,739 shares worth $5.44M.
- CVI Holdings added most to RTB Digital in Q2 2024, an estimated $151K increase.
- CVI Holdings's biggest Q2 2024 reduction was Achieve Life Sciences, cutting an estimated $2.39M.
- CVI Holdings fully exited Spire Global in Q2 2024, selling an estimated $3.13M.
- CVI Holdings's ten largest holdings make up 78% of its $116M portfolio in Q2 2024.
- CVI Holdings opened 31 new positions and closed 45 in Q2 2024.
- CVI Holdings's portfolio value rose 9.2% quarter-over-quarter to $116M.
Based on CVI Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.